Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.89M | -5.76M | -5.65M | -5.72M | -5.76M |
| Total Depreciation and Amortization | 1.45M | 1.71M | 1.97M | 1.97M | 1.96M |
| Total Amortization of Deferred Charges | 16.00K | -80.40K | -180.20K | -90.30K | -4.40K |
| Total Other Non-Cash Items | 766.00K | 562.10K | 361.70K | 155.20K | -57.50K |
| Change in Net Operating Assets | -337.90K | -816.00K | -1.30M | -1.30M | -1.30M |
| Cash from Operations | -4.00M | -4.39M | -4.79M | -4.98M | -5.15M |
| Capital Expenditure | -191.50K | -131.40K | -72.70K | -105.60K | -137.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.00K | -36.60K | -30.40K | -52.50K | -74.40K |
| Cash from Investing | -234.30K | -167.90K | -103.00K | -158.10K | -212.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -613.00K | -574.50K | -536.00K | -527.00K | -518.00K |
| Issuance of Common Stock | 6.17M | 6.80M | 7.43M | 7.43M | 7.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.51M | 4.01M | 4.54M | 4.54M | 4.55M |
| Foreign Exchange rate Adjustments | -82.90K | 16.80K | 114.40K | 58.70K | 1.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -799.40K | -529.20K | -242.80K | -540.80K | -810.50K |